Dr. Andrew Krinsky, MD

NPI: 1518064054
Total Payments
$6,044
2022 Payments
$16.97
Companies
8
Transactions
23

Payment Breakdown by Category

Research$5,650 (93.5%)
Food & Beverage$340.06 (5.6%)
Education$53.98 (0.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $5,650 1 93.5%
Food and Beverage $340.06 20 5.6%
Education $53.98 2 0.9%

Payments by Type

Research
$5,650
1 transactions
General
$394.04
22 transactions

Top Paying Companies

Company Total Records Latest Year
Rapid Pathogen Screening, Inc. $5,650 1 $0 (2020)
Mission Pharmacal Company $180.68 11 $0 (2021)
Astellas Pharma US Inc $141.26 6 $0 (2018)
ABBVIE INC. $16.97 1 $0 (2022)
Theravance Biopharma Inc. $16.03 1 $0 (2017)
Evofem Biosciences, Inc. $14.63 1 $0 (2021)
Philips Electronics North America Corporation $14.07 1 $0 (2018)
Allergan Inc. $10.40 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2022 $16.97 1 ABBVIE INC. ($16.97)
2021 $28.74 2 Evofem Biosciences, Inc. ($14.63)
2020 $5,650 1 Rapid Pathogen Screening, Inc. ($5,650)
2019 $27.79 2 Mission Pharmacal Company ($27.79)
2018 $120.67 6 Mission Pharmacal Company ($77.61)
2017 $199.87 11 Astellas Pharma US Inc ($112.27)

All Payment Transactions

23 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
02/22/2022 ABBVIE INC. LO LOESTRIN FE (Drug) Food and Beverage In-kind items and services $16.97 General
Category: WOMENS HEALTH
04/27/2021 Mission Pharmacal Company Uribel (Drug) Food and Beverage In-kind items and services $14.11 General
Category: Analgesic, antispasmodic & antiseptic (urinary)
01/07/2021 Evofem Biosciences, Inc. Phexxi (Drug) Food and Beverage In-kind items and services $14.63 General
Category: Miscellaneous vaginal agent
07/06/2020 Rapid Pathogen Screening, Inc. FebriDx (Device) Cash or cash equivalent $5,650.00 Research
Study: FebriDx • Category: Diagnostic Device
06/19/2019 Mission Pharmacal Company Uribel (Drug) Food and Beverage In-kind items and services $15.14 General
Category: Analgesic, antispasmodic & antiseptic (urinary)
01/16/2019 Mission Pharmacal Company Binosto (Drug) Food and Beverage In-kind items and services $12.65 General
Category: Anti-osteoporotic
11/27/2018 Philips Electronics North America Corporation Zoom Kits (Device) Food and Beverage Cash or cash equivalent $14.07 General
Category: Cardiology/Vascular Diseases
11/23/2018 Mission Pharmacal Company Uribel (Drug) Food and Beverage In-kind items and services $20.48 General
Category: Analgesic, antispasmodic & antiseptic (urinary)
08/20/2018 Mission Pharmacal Company Food and Beverage In-kind items and services $23.45 General
07/25/2018 Astellas Pharma US Inc Education In-kind items and services $28.99 General
04/03/2018 Mission Pharmacal Company Uribel (Drug) Food and Beverage In-kind items and services $21.05 General
Category: Analgesic, antispasmodic & antiseptic (urinary)
02/13/2018 Mission Pharmacal Company Uribel (Drug) Food and Beverage In-kind items and services $12.63 General
Category: Analgesic, antispasmodic & antiseptic (urinary)
12/10/2017 Mission Pharmacal Company Binosto (Drug) Food and Beverage In-kind items and services $16.10 General
Category: Anti-osteoporotic
11/02/2017 Mission Pharmacal Company Binosto (Drug) Food and Beverage In-kind items and services $12.46 General
Category: Anti-osteoporotic
10/25/2017 Allergan Inc. LO LOESTRIN FE (Drug) Food and Beverage In-kind items and services $10.40 General
Category: WOMENS HEALTH
08/29/2017 Astellas Pharma US Inc Myrbetriq (Drug), Vesicare Food and Beverage In-kind items and services $21.21 General
Category: Urology
08/09/2017 Mission Pharmacal Company Uribel (Drug) Food and Beverage In-kind items and services $10.60 General
Category: Analgesic, antispasmodic & antiseptic (urinary)
07/05/2017 Mission Pharmacal Company Binosto (Drug) Food and Beverage In-kind items and services $22.01 General
Category: Anti-osteoporotic
06/15/2017 Theravance Biopharma Inc. VIBATIV (Drug) Food and Beverage In-kind items and services $16.03 General
Category: Infectious Disease
05/10/2017 Astellas Pharma US Inc Myrbetriq (Drug), Vesicare Food and Beverage In-kind items and services $22.38 General
Category: Urology
05/04/2017 Astellas Pharma US Inc Education In-kind items and services $24.99 General
03/13/2017 Astellas Pharma US Inc Myrbetriq (Drug), Vesicare Food and Beverage In-kind items and services $22.22 General
Category: Urology
01/26/2017 Astellas Pharma US Inc Myrbetriq (Drug), Vesicare Food and Beverage In-kind items and services $21.47 General
Category: Urology

Research Studies & Clinical Trials

Study Name Company Amount Records
FebriDx Rapid Pathogen Screening, Inc. $5,650 1

About Dr. Andrew Krinsky, MD

Dr. Andrew Krinsky, MD is a Infectious Disease healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518064054.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Krinsky, MD has received a total of $6,044 in payments from pharmaceutical and medical device companies, with $16.97 received in 2022. These payments were reported across 23 transactions from 8 companies. The most common payment nature is "" ($5,650).

Practice Information

  • Specialty Infectious Disease
  • Location Sarasota, FL
  • Active Since 09/19/2006
  • Last Updated 10/14/2019
  • Taxonomy Code 207RI0200X
  • Entity Type Individual
  • NPI Number 1518064054

Products in Payments

  • FebriDx (Device) $5,650
  • Uribel (Drug) $94.01
  • Myrbetriq (Drug) $87.28
  • Binosto (Drug) $63.22
  • LO LOESTRIN FE (Drug) $27.37
  • VIBATIV (Drug) $16.03
  • Phexxi (Drug) $14.63
  • Zoom Kits (Device) $14.07

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Infectious Disease Doctors in Sarasota